Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Planned sale Chief Legal Officer sold 117 shares at $94.34 ($11,038)
  2. 4 Planned sale President sold 309 shares at $94.34 ($29,151)
  3. 4 Planned sale Chief Financial Officer sold 647 shares at $94.57 ($61,188)
  4. 4 Planned sale Chief Legal Officer sold 670 shares at $94.57 ($63,363)
  5. 4 Planned sale President sold 2,388 shares at $94.57 ($225,838)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale President sold 15,000 shares at $100.00 ($1,500,000)
  11. 4 Planned sale President sold 10,542 shares at $88.88 ($936,981)
  12. 4 Planned sale Chief Executive Officer sold 26,351 shares at $88.88 ($2,342,098)
  13. 4 Planned sale President sold 304 shares at $86.23 ($26,214)
  14. 4 Planned sale President sold 15,000 shares at $103.90 ($1,558,500)
  15. 4 Planned sale Chief Financial Officer sold 772 shares at $109.75 ($84,731)
  16. 4 Planned sale President sold 45,000 shares at $100.01 ($4,500,450)
  17. 4 Planned sale Chief Legal Officer sold 563 shares at $79.09 ($44,525)
  18. 4 Planned sale Chief Commercial Officer sold 564 shares at $78.34 ($44,182)
  19. 4 Planned sale Chief Legal Officer sold 111 shares at $79.31 ($8,804)
  20. 4 Planned sale President sold 309 shares at $79.31 ($24,508)

Page 10 of 54 · 1,067 filings